People: BioScrip Inc (BIOS.O)

BIOS.O on Nasdaq

6.12USD
19 Dec 2014
Price Change (% chg)

$-0.04 (-0.57%)
Prev Close
$6.16
Open
$6.14
Day's High
$6.21
Day's Low
$5.98
Volume
1,639,991
Avg. Vol
1,021,841
52-wk High
$9.05
52-wk Low
$5.44

Search Stocks

Collins, Charlotte 

Brief Biography

Ms. Charlotte W. Collins, Esq., is an Independent Director of BioScrip Inc., since April 2003. Since January 2008, she has been a senior executive in charge of policy for the Asthma and Allergy Foundation of America (the “Foundation”). Since 2010, Ms. Collins has also been in charge of education programs for the Foundation and is currently its Senior Vice President for Policy and Programs. From 2003 to 2007, she was Associate Professor of Health Services Management and Leadership, and Health Policy at the George Washington University School of Public Health and Health Services. From January 2002 to June 2003, she was an Associate Research Professor of Health Policy at the same university. She served a four year term on the National Allergy and Infectious Diseases Advisory Council of the National Institutes of Health beginning in 2001. From September 1996 to November 2004, Ms. Collins was Of Counsel in the health policy practice of the law firm of Powell, Goldstein LLP in its Washington DC office. She served as General Counsel of the Regional Medical Center at Memphis for ten years until 1996 and served as interim General Counsel for the District of Columbia Health and Hospitals Public Benefit Corporation in 1998. In 1993, Ms. Collins co-founded a managed care plan and served on its board of directors through 1996. She has also served on the boards of two primary care centers, a Medicare Part A intermediary company, and as a leadership coach for the Robert Wood Johnson Foundation’s Health Policy Fellows program. In 2006, Modern Healthcare magazine named her one of the top 25 most influential minority healthcare executives.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Myron Holubiak

--

Richard Smith

2,328,120

Hai Tran

1,670,960

Thomas Pettit

--

Brian Stiver

874,015

Vito Ponzio

828,219
As Of 30 Dec 2013
Search Stocks